Rate My Professor Eoin McKinney

Professor Eoin McKinney serves as the Versus Arthritis Professor of Rheumatology and Professor of Clinical Autoimmunity in the Department of Medicine at the University of Cambridge. He is a Fellow of Pembroke College, an honorary consultant in nephrology and transplantation at Cambridge University Hospitals NHS Foundation Trust, and a faculty member of the Cambridge Centre for Artificial Intelligence in Medicine. Previously recognized as a Wellcome Trust Fellow and Wellcome-Beit Research Fellow, McKinney maintains an active clinical practice as a nephrologist while leading pioneering research into the mechanisms of severe, relapsing autoimmune diseases. His laboratory, the McKinney Group, adopts a systems immunology approach to investigate the interface between protective immune responses to persistent infections and pathological responses to self-antigens. By integrating multi-omics datasets with machine learning techniques, the group models quantitative immune traits to reveal novel relationships underlying dysfunctional immunity in conditions such as ANCA-associated systemic vasculitis and systemic lupus erythematosus (SLE). This work facilitates the development of interpretable predictive models for clinical translation, enhancing disease biology insights, biomarker discovery, and identification of therapeutic strategies for inflammatory pathologies.

McKinney's earlier investigations utilized custom spotted oligo microarray platforms to profile gene expression signatures in leukocyte subsets (CD4, CD8, CD14, CD16, CD19, and unseparated PBMC) from patients with active disease, followed longitudinally after therapy. These studies correlated molecular profiles with detailed clinical monitoring to identify diagnostic and prognostic biomarkers. His influential publications include 'T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection' (Nature, 2015), which examined T-cell dysfunction across infections and autoimmunity; 'Metabolic exhaustion in infection, cancer and autoimmunity' (Nature Immunology, 2018), exploring metabolic pathways in immune-mediated diseases; and 'Analysis of the B cell receptor repertoire in six immune-mediated diseases' (Nature, 2019), providing insights into B-cell diversity in pathology. Additional key works encompass 'A blood-based prognostic biomarker in IBD' (Gut, 2019) and 'From Big Data to Precision Medicine' (Frontiers in Medicine, 2019). McKinney's contributions have advanced the understanding of T-cell exhaustion, immune ageing, and precision approaches to autoimmunity, influencing clinical management and therapeutic innovation in rheumatology and beyond.